Previous close | 0.0900 |
Open | 0.2200 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 40.00 |
Expiry date | 2024-05-17 |
Day's range | 0.0900 - 0.2200 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see GSK plc...
GSK plc's ( LON:GSK ) investors are due to receive a payment of £0.15 per share on 11th of July. The dividend yield...
Strategic collaboration with GSK expanded to accelerate clinical development of alpibectir for the treatment of tuberculosisGSK to participate in Series C Extension with equity investmentSeries C financing round extended overall by CHF 12.3 million to CHF 44.9 million BASEL, Switzerland, May 07, 2024 (GLOBE NEWSWIRE) -- BioVersys AG, a multi-asset, clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious life-threatening infections